Skip to content


  • Research article
  • Open Access
  • Open Peer Review

Common adult psychiatric disorders in Swedish primary care where most mental health patients are treated

BMC PsychiatryBMC series – open, inclusive and trusted201717:235

  • Received: 24 February 2017
  • Accepted: 6 June 2017
  • Published:
Open Peer Review reports



The overall aim of this study is to present descriptive data regarding the treated prevalence of nine common psychiatric and substance use disorders in the first Primary Care Registry (PCR) in Sweden: Major Depression (MD), Anxiety Disorders (AD), Obsessive-Compulsive Disorder (OCD), Adjustment Disorder (AdjD), Eating Disorders (ED), Personality Disorder (PD), Attention Deficit Hyperactivity Disorder (ADHD), Alcohol Use Disorder (AUD) and Drug Abuse (DA).


We selected 5,397,675 individuals aged ≥18. We examined patterns of comorbidity among these disorders and explored the association between diagnoses in the PCR and diagnoses obtained from Hospital and Specialist care. We explored the proportion of patients with these nine disorders that are only treated in primary health care.


For four of our disorders, 80% or more of the cases were present only in the PCR: AdjD, DA, AD and MD. For two disorders (OCD and ED), 65–70% of cases were only found in the PCR. For three disorders (PD, AUD, and ADHD), 45–55% of the patients were only present in the PCR.


The PCR will, in the future, likely prove to be an important tool for studies in psychiatric epidemiology.


  • Mental disorders
  • Mental health
  • Personality
  • Population characteristics


Mood disorders, anxiety disorders, and stress- and adjustment disorders together account for a large portion of the disease burden in Western countries. In Sweden, according to a 2009 [1] study, depression and anxiety were among the 25 diseases with the highest insurance costs. In the 2010 Global Burden of Disease Study, depression and anxiety were ranked second and seventh in their worldwide impact on disease-related disability [2]. Most of these patients are likely seen by a general practitioner (GP), although a previous Swedish study [3] suggested that only 25% of the cases of depression and anxiety are identified in primary health care in the country.

There are limited nationwide studies in western countries on incidence and prevalence of common psychiatric disorders in primary health care. However, it is probable that a large proportion of such disorders are treated only in primary health care. Two questionnaire-based studies [3, 4], where data were collected in waiting rooms in primary health care centres in Sweden, observed that between 3.7 and 6.2% of patients had symptoms of depression; between 11.8 and 13.5% had symptoms of anxiety. Studies [5, 6] conducted in the United Kingdom, which has a highly developed primary health care system, estimated the incidence of depression to be 13.9 and anxiety to be 9.7 per 1000 person-years. In Belgium [7], incidence rates of depression diagnosed in primary health care were found to be 7.2 in men and 14.4 in women, per 1000 person-years. In a previous Swedish study [8], the 12-month prevalence of clinically diagnosed mood, anxiety and stress- and adjustment disorders was 2.4% (3.2% in women and 1.5% in men). The authors used data from a regional primary health care register from Stockholm, Värmland, Uppsala and Gotland comprising of 75 primary health care centres. None of these studies estimated the proportion of cases that were only treated in primary care.

Swedish registries have provided a tremendous resource for the study of the epidemiology and genetic epidemiology of psychiatric disorders [914]. However, up until now, the ascertainment of individuals with psychiatric disorders has been restricted to hospital-based diagnoses using the Hospital Discharge Register and specialist out-patient diagnoses from the Outpatient Care Register.

Aims of the study

The first aim of this study is to present descriptive data regarding the treated prevalence of nine relatively common psychiatric and substance use disorders in the first Primary Care Registry (PCR) available in Sweden, which now covers approximately 72% of the Swedish population. The PCR is a research dataset including nationwide longitudinal individual based information on diagnoses and time for diagnoses; providing valuable information on the occurrence and course for common psychiatric disorders and could be linked to several different Swedish population-based registers that have nationwide coverage.

The nine common psychiatric and substance use disorders were: Major Depression (MD), Anxiety Disorders (AD), Obsessive-Compulsive Disorder (OCD), Adjustment Disorder (AdjD), Eating Disorders (ED), Personality Disorder (PD), Attention Deficit Hyperactivity Disorder (ADHD), Alcohol Use Disorder (AUD) and Drug Abuse (DA). We chose these disorders because they would often be seen and cared for in primary care settings as opposed to the rarer and more severe disorders such as bipolar illness, schizophrenia or autism that would usually be treated in speciality settings. The second aim is to examine patterns of comorbidity among these disorders, and explore the association between diagnoses in the PCR and i) diagnoses obtained from the Hospital and Specialist care, ii) treatment with common classes of psychopharmacologic agents, iii) personal and parental educational status and iv) marital status. Third, we attempt to validate these disorders in several ways including resemblance in full siblings (as a long established method for validating psychiatric disorders [15]) treatment with specific classes of psychopharmacological agents, social class of origin, and educational and marital status. By validation, we mean evidence that having the diagnosis predicts additional meaningful clinical information external to the diagnostic process. Finally, we demonstrate the proportion of patients with nine common psychiatric disorders that are only treated in primary health care.


The Primary Care Register (PCR) is a research dataset including individual-level information such as diagnoses based on visits to primary health care centres in the following regions in Sweden: Värmland (during 2005–2015), Uppsala Län (2005–2015), Västernorrland (2008–2015), Norrbotten (2001–2014), Halland (2007–2014), Skåne (1998–2013), Östergötland (1998–2014), Stockholm (2003–2016), and Västra Götaland (2000–2013). The time periods are different depending on the time before digitalising the patient records. In 2015 these nine counties contained 72% of the population living in Sweden. In total there were 208,624,743 registrations from 7,372,164 individuals. The aim is to include almost all of the Swedish population into the PCR. Each registration included the unique individual Swedish 10-digit personal ID number, which is assigned at birth or immigration to all Swedish residents, date of the visit, and the ICD 10 code. The ID number was replaced by a random number to preserve confidentiality. The PCR could be linked to several different Swedish population-based registers with national coverage (i.e. Hospital Discharge Register, Outpatient Care Register, Prescribed Drug Register and the Multi-Generation Register). We secured ethical approval for this study from the Regional Ethical Review Board of Lund University (No. 2008/409).

From the PCR we selected all individuals with at least one registration at age 18 or older (N = 5,397,675). We identified all individuals with at least one of nine diagnoses defined in Table 1. Based on the tetrachoric correlation matrix (Table 2), we used an exploratory factor analysis (EFA) to identify the underlying relationships between the nine diagnoses. The purpose with the factor analysis is to describe the variability and patterns of comorbidity among the nine psychiatric and substance use disorders by a small number of factors.
Table 1

Individuals registered by diagnostic category at least once in the PHC-database 1998 and onwards and 18 years or older at first registration



Number registered (%)

Total N = 5,397,675

Sex ratio in prevalence (females/males)

Major Depression

F32, F33

670,980 (12.4%)

1.90 (1.89; 1.91)

Anxiety Disorders

F40, F41

536,279 (9.9%)

1.81 (1.80; 1.82)

Obsessive-Compulsive Disorder


17,941 (0.3%)

1.42 (1.38; 1.46)

Adjustment Disorder


498,960 (9.2%)

2.37 (2.36; 2.39)

Eating Disorders


12,633 (0.2%)

10.33 (9.70; 11.01)

Personality Disorder

F60, F61

16,743 (0.3%)

1.59 (1.54; 1.64)

Attention Deficit Hyperactivity Disorder


25,891 (0.5%)

0.81 (0.79; 0.83)

Alcohol Use Disorder


109,415 (2.0%)

0.49 (0.39; 0.40)

Drug Abuse


142,118 (2.6%)

0.98 (0.97; 0.99)

Table 2

Tetrachoric correlations (± SEs) and ORs (with 95% confidence intervals) between different diagnosesa











Major Depression (MD)


10.0 (9.9; 10.1)

8.3 (8.1; 8.6)

6.5 (6.5; 6.6)

8.3 (8.0; 8.6)

14.1 (13.6; 14.5)

7.8 (7.6; 8.0)

4.2 (4.1; 4.2)

3.4 (3.4; 3.5)

Anxiety Disorders (AD)

0.64 (0.01)


16.0 (15.5; 16.5)

5.8 (5.8; 5.9)

9.7 (9.3; 10.0)

19.0 (18.4; 19.6)

10.0 (9.7; 10.2)

4.7 (4.6; 4.7)

4.0 (4.0; 4.1)

bsessive-Compulsive Disorder (OCD)

0.41 (0.00)

0.52 (0.00)


4.1 (4.0; 4.2)

18.8 (17.4; 20.3)

26.0 (24.5; 27.6)

15.3 (14.4; 16.3)

3.6 (3.4; 3.8)

3.0 (2.8; 3.1)

Adjustment Disorder (AdjD)

0.53 (0.00)

0.49 (0.00)

0.26 (0.00)


4.6 (4.5; 4.8)

7.2 (7.0; 7.4)

4.8 (4.6; 4.9)

2.3 (2.3; 2.4)

2.6 (2.5; 2.6)

Eating Disorders (ED)

0.40 (0.00)

0.42 (0.00)

0.40 (0.01)

0.28 (0.00)


35.2 (33.1; 37.4)

13.9 (12.9; 14.9)

3.9 (3.7; 4.2)

2.9 (2.8; 3.1)

Personality Disorder (PD)

0.50 (0.00)

0.55 (0.00)

0.47 (0.01)

0.37 (0.00)

0.51 (0.01)


50.1 (48.0; 52.2)

12.7 (12.2; 13.2)

11.3 (10.9; 11.7)

Attention Deficit Hyperactivity Disorder (ADHD)

0.41 (0.00)

0.46 (0.00)

0.40 (0.01)

0.31 (0.00)

0.37 (0.01)

0.60 (0.00)


10.1 (9.7; 10.4)

11.0 (10.7; 11.3)

Alcohol Use Disorder (AUD)

0.34 (0.00)

0.36 (0.00)

0.19 (0.00)

0.19 (0.00)

0.20 (0.01)

0.42 (0.00)

0.40 (0.00)


10.4 (10.3; 10.6)

Drug Abuse (DA)

0.30 (0.00)

0.33 (0.00)

0.17 (0.00)

0.22 (0.00)

0.16 (0.01)

0.41 (0.00)

0.43 (0.00)

0.49 (0.00)


aCorrelations below diagonal and ORs above

We then used the same ICD codes, as defined in Table 1, to identify individuals with a registration in the Specialist Outpatient Care Register (during 2001–2012) and the Hospital Discharge Register (during 1969–2012). Furthermore, from the Prescribed Drug Register, we defined individuals that had collected at least one prescription of Antidepressants (ATC-code N06A), Anxiolytics (ATC-code N05B) and Stimulants (ATC-code N06B). This register records information on sales of prescribed pharmaceutical agents dispensed by the Swedish Corporation of Pharmacies.


To provide evidence of the potential validity of these diagnoses, we first studied the correlation among full sibling pairs for each diagnosis. In the PCR we identified 2,190,806 unique full sibling pairs (excluding twin pairs). Second, we studied the association between educational attainment and the diagnoses for all individuals born prior to 1990 (n = 5,141,890). The education variable was based on information from the education register the number of years of education (1:<9 years; 2: 9 years; 3: 10–11 years; 4: 12 years; 5: 13–15 years; 6: 16 years or more; 7: PhD/ licentiate degree; groups 5,6 and 7 include education at university level). The education register (UREG) holds statistics of the Swedish population educational level. In order to be able to compare the variable over time, we standardised the variable (mean 0 and std. 1) by gender and year of birth. Third, to measure the association between social class and diagnosis, we used mean parental education (measured the same way as explained above) as a proxy for social class. We were able to identify parental educational status in 3,366,585 individuals. Finally, we identified individuals that, sometime during the period 1998–2014, were registered as married as well as individuals that were registered as divorced. We studied the association between marital status (yes/no) and divorce (yes/no) and the above defined diagnoses using logistic regression while controlling for year of birth and gender. All statistical analyses were performed using SAS 9.3. [16]


Table 1 depicts the prevalence in our treated sample of each of the nine disorders of interest, which varied from a low of 0.2% for EDs to a high of 12.4% for MD. This table also shows the sex ratio in prevalence. Males have higher prevalence for three disorders (ADHD, DA and AUD) and females for the remaining six: MD, AD, OCD, AdjD, ED and PDs.

The observed patterns of comorbidity are seen in Table 2 both as ORs (above the diagonal) and tetrachoric correlations (below the diagonal). Focusing on the ORs, they were all significantly greater than unity and were particularly high between PDs and all other diagnoses, among AUD, ADHD and DA, among MD, AD and OCD, and between ED and OCD. The raw proportion and total numbers of individuals with each of these comorbidities is depicted in Table 3.
Table 3

– Patterns of comorbidities showing the raw proportions and total number of individuals with specific comorbid patterns of diagnoses











Major Depression (MD)










Anxiety Disorders (AD)










Obsessive-Compulsive Disorder (OCD)










Adjustment Disorder (AdjD)










Eating Disorders (ED)










Personality Disorder (PD)










Attention Deficit Hyperactivity Disorder (ADHD)










Alcohol Use Disorder (AUD)










Drug Abuse (DA)










*% above diagonal and number below diagonal

We applied an exploratory factor analysis to a tetrachoric correlation matrix for all of the diagnoses. The scree plot had only one factor with an Eigen value of greater than one. Table 4 shows the loadings of that single factor, which were lowest for DA and AUD and highest for PD, AD and MD.
Table 4

Factor loadings on a single factor from an exploratory factor analysis


Factor loadings

Major Depression


Anxiety Disorders


Obsessive-Compulsive Disorder


Adjustment Disorder


Eating Disorders


Personality Disorder


Attention Deficit Hyperactivity Disorder


Alcohol Use Disorder


Drug Abuse


We next examined the association between the diagnoses recorded in the PCR with those obtained from specialist and in-patient care (Table 5). These ORs were uniformly high but quite variable across the different disorders, and consistently higher between the PCR and specialist care than between the PCR and in-patient diagnoses. These ORs were much higher for four of the diagnostic categories (OCD, ED, PD and ADHD), which suggests that primary care GPs were especially likely to refer such cases to specialist or in-patient care. By contrast, these ORs were relatively low for MD, AD and AdjD.
Table 5

Sources of registration of cases in the primary care registry and the proportion treated with antidepressants, anxiolytics and stimulants


OR (95% CI) for disorder in

Percent of PCR Cases that are

Percent of PCR cases that are prescribed


PCR and specialist care

PCR and inpatient

Only in PCR

Also in specialist care

Also in inpatient




Major Depression

15.9 (15.8; 16.2)

10.3 (10.2; 10.5)







Anxiety Disorders

18.8 (18.6; 19.0)

11.7 (11.4; 11.9)







Obsessive-Compulsive Disorder

403.5 (387.2; 420.4)

190.1 (173.2; 208.7)







Adjustment Disorder

10.5 (10.4; 10.7)

5.6 (5.5, 5.7)







Eating Disorders

425.9 (407.2; 445.4)

257.8 (240.0; 277.1)







Personality Disorder

327.7 (316.7; 339.1)

117.3 (112.0; 123.0)







Attention Deficit Hyperactivity Disorder

344.3 (334.1; 354.6)

144.0 (133.3; 155.4)







Alcohol Use Disorder

136.2 (134.0; 138.5)

65.2 (64.2; 66.3)







Drug Abuse

49.4 (48.4; 50.5)

27.5 (26.9; 28.0)







We calculated the proportion of individuals with our nine disorders in the PCR who were also registered with the same diagnosis in the specialist and in-patient registries (Table 5). For four of our disorders, 80% or more of the cases were present only in the PCR: AdjD, DA, AD and MD. For two of the disorders (OCD and ED), 65–70% of cases were only found in the PCR. For the remaining three disorders (PD, AUD, and ADHD), 45–55% of the patients were only present in the PCR.

For AUD and DA, we were also able to compare our PCR diagnoses with registrations in the criminal registry. We found ORs of 25.22 (24.57–25.88) for AUD and 11.99 (11.79; 12.19) for DA.

We were also able to match our PCR cases with the pharmacy registry and show in Table 5 the proportion that had filled prescriptions for anti-depressants, anxiolytics and stimulants. Antidepressants prescriptions were uniformly high across all the diagnoses with the highest treatment rates seen in PD, MD and OCD. High rates of anxiolytics prescriptions were also widespread across these psychiatric disorders, with highest rates for PDs and ADs. Stimulants, by contrast, were rarely prescribed for all categories except ADHD and, more modestly, for PDs. We also show the percentage of patients prescribed these three classes of medication who were only registered in the PCR database (Table 6), thereby depicting the prescription patterns of the primary care physicians. They are relatively similar to those seen in all patients, although the rates are somewhat lower, especially for stimulant treatment of patients with ADHD.
Table 6

The proportion of cases only registered in the primary care registry that were treated with antidepressants, anxiolytics and stimulants


Percent of PCR cases only registered in PCR that are prescribed





Major Depression




Anxiety Disorders




Obsessive-Compulsive Disorder




Adjustment Disorder




Eating Disorders




Personality Disorder




Attention Deficit Hyperactivity Disorder




Alcohol Use Disorder




Drug Abuse




Table 7 examines a range of additional potential validators for these common psychiatric diagnoses. All of the disorders were familial with tetrachoric correlations in full siblings ranging from +0.15 for MD and AdjD to +0.36 for ADHD. All of the diagnoses were associated with reduced educational attainment, with the association being strongest for ADHD and DA and weakest with AdjD. We indexed social class of origin by parental educational attainment and found that diagnoses of OCD, PD and ED were all associated with higher social class, while DA stood out as having by far the strongest association with a lower social class of origin.
Table 7

Siblings correlations, self- and parental-educational status and marital status by diagnosis


Sibling correlations

Education – ORa

Mean parental education ORb







Major Depression

0.15 (0.00)

0.89 (0.89; 0.90)

0.97 (0.96; 0.97)


0.87 (0.86; 0.87)


1.59 (1.58; 1.60)

Anxiety Disorders

0.18 (0.00)

0.83 (0.83; 0.84)

0.94 (0.94; 0.94)


0.77 (0.77; 0.78)


1.46 (1.45; 1.47)

Obsessive-Compulsive Disorder

0.23 (0.01)

0.90 (0.89; 0.92)

1.06 (1.04; 1.08)


0.53 (0.52; 0.55)


1.10 (1.06; 1.15)

Adjustment Disorder

0.15 (0.00)

0.95 (0.95; 0.96)

0.97 (0.97; 0.97)


1.16 (1.16; 1.17)


1.88 (1.87; 1.90)

Eating Disorders

0.23 (0.01)

0.90 (0.89; 0.92)

1.11 (1.09; 1.13)


0.56 (0.54; 0.58)


1.41 (1.34; 1.48)

Personality Disorder

0.29 (0.01)

0.69 (0.67; 0.70)

1.08 (1.06; 1.10)


0.39 (0.38; 0.41)


2.02 (1.95; 2.09)

Attention Deficit Hyperactivity Disorder

0.36 (0.01)

0.58 (0.57; 0.59)

0.96 (0.95; 0.98)


0.50 (0.49; 0.51)


1.88 (1.82; 1.95)

Alcohol Use Disorder

0.22 (0.00)

0.71 (0.71; 0.72)

0.92 (0.91; 0.93)


0.48 (0.47; 0.48)


2.48 (2.45; 2.51)

Drug Abuse

0.22 (0.00)

0.60 (0.59; 0.60)

0.78 (0.77; 0.78)


0.64 (0.64; 0.65)


2.16 (2.13, 2.18)







aEducation is standardized by Year of Birth and gender. Only individuals 25 years and older are included. The OR illustrates the decreased odds per 1 SD increase in education.

bSample size N = 3,366,585 as parental educational status not available on the oldest members of the PCR. The OR illustrates the decreased odds per 1 SD increase in education.

cControlling for year of birth and sex

Finally, we examined marital status and found that eight of our nine disorders (all but AdjD) were associated with a reduced probability of marriage (correcting for age) with the reduction being strongest for PD, ADHD and OCD. The probability of divorce was increased for all diagnostic categories, and was strongest for AUD, DA and PD and weakest for OCD.


This is the first paper to report that of all cases of AdjD, DA, AD and MD found in the primary health care register, 80% were not found in the outpatient/inpatient registers, indicating that a large majority of the psychiatric consultations occur in primary health care. A factor analysis of our results suggested that the pattern of comorbidity across these nine disorders could be explained by a single latent factor. We did not see evidence for separate factors of internalizing disorders (most typically anxiety and depression) and externalizing disorders (often ADHD and substance abuse syndromes) as has often been seen in other epidemiological interview based studies [17, 18].

We are also the first to demonstrate a novel association between psychiatric disorders in primary health care and specialist psychiatric care. Another interesting finding is the reasonable estimate for MD prevalence -- 12.4% -- well within the range reported previously from large population based survey studies [19] and only modestly lower than that reported from an interview based survey in neighbouring Norway [20]. We could also confirm that men have higher prevalence for ADHD, DA and AUD while women for ND, AD, OCD, AdjD, ED and PDs. This is in agreement with previous research [21] that women had elevated rates of anxiety and depressive disorders and that men had higher prevalence for drug and alcohol abuse.

We emphasise that PCR covers most of the visits to primary health care in Sweden. It is known that, across a two-year span, the entire Swedish population will have visited a primary health care centre regarding any health problem. Our finding that only a low proportion of the patients in PCR were also registered with the same diagnosis in the specialist and in-patient registries is also new. No such data has ever been presented previously. For four of our disorders, 80% or more of the cases were present only in the PCR: AdjD, DA, AD and MD, an expected finding that has now been confirmed.

The gender differences in this report (female: male ratio of 1.9) agreed with other studies demonstrating that female gender is one of the most consistent and stable factors associated with depression. An overall 1-year female/male ratio of 2/1 has been shown in the past [22, 23]. A population based epidemiologic study [19], using survey data from 10 different countries, also showed that rates of major depression were higher for women than men.

For two of the disorders (OCD and ED), 65–70% were only found in the PCR. This is an unexpected finding because such disorders might be expected to be treated predominantly in specialist psychiatric care. For the remaining three disorders (PD, AUD, and ADHD), 45–55% of the patients were only present in the PCR and would normally also be treated in specialist psychiatric care. Our findings imply that an increasing number of GPs may be taking care of their patients with psychiatric problems without seeking referral to specialist care.

We suggest introducing a new term, primary health care psychiatry, for the concept of treating such disorders in primary health care. Many of these centres already have psychologists and counsellors, as well as interested doctors, that would like to receive more specific training to aid in their treatment for these disorders.

It is not easy to compare our nationwide data on prevalence and incidence rates of ADHD, DA and AUD, MD, AD, OCD, AdjD, ED and PDs with those of previous studies [57]. For example, previous studies [3, 4] in primary health care settings in Sweden reported prevalence rates of MD of 12.5–19.7%. In a previous study [8], which included registry data from 75 primary health care centres in mid-Sweden (mostly Stockholm), the overall 12-month prevalence rate was 3.2% in women and 1.5% in men. However, previous studies [3, 4] used screening tools to identify symptoms of depression and anxiety in primary health care settings, from which they estimated the prevalence and incidence.

Validation of the PCR

Firstly, our results support the validity of these diagnoses within the PCR and the potential value of this registry as a resource, through linkage to a wide array of other Swedish registries, for the study of the epidemiology and genetic epidemiology of common psychiatric disorders.

Secondly, our results support previous research that psychiatric diagnoses examined in this study are associated with low educational status [21, 24, 25] . In the PCR, all of the diagnoses were associated with reduced educational attainment, with the association being strongest for ADHD and DA and weakest with AdjD.

Third, we measured the association between social class operationalised as mean parental education and diagnose of interest as a proxy for social class and found that diagnoses of OCD, PD and ED were all associated with higher social class, while DA stood out as having by far the strongest association with a lower social class of origin. These findings were in agreement with other studies.

Fourth, in broad agreement with other studies [21, 24, 25] we found that nearly all of our nine disorders were associated with a decreased probability of marriage and an increased probability of divorce with the association with divorce being strongest for the drug use disorders of DA and AUD.

Fifth, we found for DA and AUD striking ORs for receipt of a diagnosis in the PCR and registration for the same condition in the criminal registry.

Finally, in the validation we found that all of the disorders were familial with tetrachoric correlations in full siblings ranging from +0.15 for MD and AdjD to +0.36 for ADHD, which was in broad agreement with prior comparable studies [2630].

Limitations and strengths

We analyse treated psychiatric disorders and are likely underestimating true population prevalence both because some individuals with psychiatric illness do not visit primary care and some who do will not report their psychiatric symptoms. We cannot rule out the presence of false-positive psychiatric diagnoses as primary care physicians will not typically have time to do comprehensive psychiatric evaluations of their patients. A major strength of this report is the large study population: 7,372,164 persons. To the best of our knowledge no other study of this size has previously been performed in primary health care. Data on the study population were obtained from Swedish counties and regions and their primary health care databases, which contain clinical information about all adult individuals registered at 75 different primary health care centres. Thus, the findings are likely to reflect the current situation in primary health care in Sweden.


This paper shows novel findings based on a new national primary health care research database, PCR, demonstrating that a large majority of all out-patient physician contacts for AdjD, DA, AD and MD occur in primary health care, and a reasonable estimate for MD prevalence; 12.4%, and confirm that women men ratio in MD is 1.9. An unexpected finding, OCD and ED, 65–70%, were only found in the PCR. The PCR will be an important tool for future studies in psychiatric and substance abuse epidemiology and genetics.



Anxiety disorders


Attention deficit hyperactivity disorder


Adjustment disorder


Alcohol Use disorder


Drug abuse


Eating disorders


Major depression


Obsessive-compulsive disorder


Primary care registry


Personality disorder



The authors wish to thank all of the funders for supporting this project and Patrick Reilly, Science Editor at Center for Primary Health Care Research, for critical reading and editing of the manuscript.


This project was supported by grants R01DA030005 from the National Institutes of Health, the Swedish Research Council (K2012-70X-15,428-08-3), the Swedish Research Council for Health, Working Life and Welfare (In Swedish: Forte; 2013–1836), the Swedish Research Council (2012–2378; 2014–10,134) and FORTE (2014–0804) as well as ALF funding from Region Skåne awarded.

The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Availability of data and materials

The data used in the present study cannot be shared as it is based on data obtained from Swedish population-based registers with national coverage.

Authors’ Contributions

All authors were responsible for the study concept and the acquisition, analysis and interpretation of data. JS drafted the manuscript and all authors carried out a critical review of the manuscript for important intellectual content. HO carried out the statistical analysis. JS, KS & KK obtained funding. All authors had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

We secured ethical approval for this study from the Regional Ethical Review Board of Lund University (No. 2008/409). Consent was not obtained as the study was based on registry information.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

Center for Primary Health Care Research, Lund University, Malmö, Sweden
Department of Psychiatry, Virginia Commonwealth University, Richmond, VA, USA
Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA, USA
Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, VA, USA


  1. Försäkringskassan: Vad kostar olika sjukdomar i sjukförsäkringen? Kostnader för sjukpenning i sjukskrivningar (över 14 dagar) samt sjukersättning och aktivitetsersättning år 2009 fördelat på diagnos (What are the costs for different diseases in Swedish sickness insurance? The cost of sick leave for reporting sick (over 14 days) and sickness compensation and active compensation in 2009 based on diagnoses). In.: Swedish Social Insurance Agency; 2011.Google Scholar
  2. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (London, England). 2012;380(9859):2163–96.View ArticleGoogle Scholar
  3. Bodlund O. Anxiety and depression as a hidden problem in primary health care. Only one case in four identified. Lakartidningen. 1997;94(49):4612–4. 4617-4618PubMedGoogle Scholar
  4. Nordstrom A, Bodlund O. Every third patient in primary care suffers from depression, anxiety or alcohol problems. Nordic journal of psychiatry. 2008;62(3):250–5.View ArticlePubMedGoogle Scholar
  5. Martin-Merino E, Ruigomez A, Johansson S, Wallander MA, Garcia-Rodriguez LA. Study of a cohort of patients newly diagnosed with depression in general practice: prevalence, incidence, comorbidity, and treatment patterns. Primary care companion to the Journal of clinical psychiatry. 2010;12(1):PCC.08m00764.PubMedPubMed CentralGoogle Scholar
  6. Martin-Merino E, Ruigomez A, Wallander MA, Johansson S, Garcia-Rodriguez LA. Prevalence, incidence, morbidity and treatment patterns in a cohort of patients diagnosed with anxiety in UK primary care. Fam Pract. 2010;27(1):9–16.View ArticlePubMedGoogle Scholar
  7. Boffin N, Bossuyt N, Declercq T, Vanthomme K, Van Casteren V. Incidence, patient characteristics and treatment initiated for GP-diagnosed depression in general practice: results of a 1-year nationwide surveillance study. Fam Pract. 2012;29(6):678–87.View ArticlePubMedGoogle Scholar
  8. Lejtzen N, Sundquist J, Sundquist K, Li X. Depression and anxiety in Swedish primary health care: prevalence, incidence, and risk factors. Eur Arch Psychiatry Clin Neurosci. 2014;264(3):235–45.View ArticlePubMedGoogle Scholar
  9. Crump C, Winkleby MA, Sundquist K, Sundquist J. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry. 2013;170(3):324–33.View ArticlePubMedGoogle Scholar
  10. Sundquist J, Ohlsson H, Sundquist K, Kendler KS. Attention-deficit/hyperactivity disorder and risk for drug use disorder: a population-based follow-up and co-relative study. Psychol Med. 2015;45(5):977–83.View ArticlePubMedGoogle Scholar
  11. Kendler KS, Ohlsson H, Sundquist K, Sundquist J. Peer deviance, parental divorce, and genetic risk in the prediction of drug abuse in a nationwide Swedish sample: evidence of environment-environment and gene-environment interaction. JAMA psychiatry. 2014;71(4):439–45.View ArticlePubMedPubMed CentralGoogle Scholar
  12. Sundquist J, Ohlsson H, Winkleby MA, Sundquist K, Crump C. School Achievement and Risk of Eating Disorders in a Swedish National Cohort. Journal of the American Academy of Child and Adolescent Psychiatry. 2016;55(1):41–46.e41.View ArticlePubMedGoogle Scholar
  13. Sundquist K, Li X, Hemminki K, Sundquist J. Subsequent risk of hospitalization for neuropsychiatric disorders in patients with rheumatic diseases: a nationwide study from Sweden. Arch Gen Psychiatry. 2008;65(5):501–7.View ArticlePubMedGoogle Scholar
  14. Kendler KS, Maes HH, Sundquist K, Ohlsson H, Sundquist J. Genetic and family and community environmental effects on drug abuse in adolescence: a Swedish national twin and sibling study. Am J Psychiatry. 2014;171(2):209–17.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry. 1970;126(7):983–7.View ArticlePubMedGoogle Scholar
  16. Anonymous: SAS Institute, SAS/STAT User's Guide, Version 9.3. Cary, NC.; 2011.Google Scholar
  17. Krueger RF. The structure of common mental disorders. Arch Gen Psychiatry. 1999;56(10):921–6.View ArticlePubMedGoogle Scholar
  18. Kendler KS, Aggen SH, Knudsen GP, Roysamb E, Neale MC, Reichborn-Kjennerud T. The structure of genetic and environmental risk factors for syndromal and subsyndromal common DSM-IV axis I and all axis II disorders. Am J Psychiatry. 2011;168(1):29–39.View ArticlePubMedGoogle Scholar
  19. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA. 1996;276(4):293–9.View ArticlePubMedGoogle Scholar
  20. Kringlen E, Torgersen S, Cramer V. A Norwegian psychiatric epidemiological study. Am J Psychiatry. 2001;158(7):1091–8.View ArticlePubMedGoogle Scholar
  21. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(1):8–19.View ArticlePubMedGoogle Scholar
  22. Fryers T, Brugha T, Morgan Z, Smith J, Hill T, Carta M, et al. Prevalence of psychiatric disorder in Europe: the potential and reality of meta-analysis. Soc Psychiatry Psychiatr Epidemiol. 2004;39(11):899–905.View ArticlePubMedGoogle Scholar
  23. Brugha TS, Matthews R, Alonso J, Vilagut G, Fouweather T, Bruffaerts R, et al. Gender differences in mental health expectancies in early- and midlife in six European countries. The British journal of psychiatry : the journal of mental science. 2013;202(4):294–300.View ArticleGoogle Scholar
  24. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593–602.View ArticlePubMedGoogle Scholar
  25. Grant BF, Goldstein RB, Chou SP, Huang B, Stinson FS, Dawson DA, et al. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol Psychiatry. 2009;14(11):1051–66.View ArticlePubMedGoogle Scholar
  26. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry. 2000;157(10):1552–62.View ArticlePubMedGoogle Scholar
  27. Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry. 2001;158(10):1568–78.View ArticlePubMedGoogle Scholar
  28. Cotton NS. The familial incidence of alcoholism: a review. J Stud Alcohol. 1979;40(1):89–116.View ArticlePubMedGoogle Scholar
  29. Merikangas KR, Stolar M, Stevens DE, Goulet J, Preisig MA, Fenton B, et al. Familial transmission of substance use disorders. Arch Gen Psychiatry. 1998;55(11):973–9.View ArticlePubMedGoogle Scholar
  30. Bulik CM, Sullivan PF, Wade TD, Kendler KS. Twin studies of eating disorders: a review. The International journal of eating disorders. 2000;27(1):1–20.View ArticlePubMedGoogle Scholar


© The Author(s). 2017